(Q48017528)

7 February 2018

title

Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin (English)

1 reference

7 February 2018

author name string

Sanchez J

1

1 reference

7 February 2018

Elgue G

2

1 reference

7 February 2018

Riesenfeld J

3

1 reference

7 February 2018

Olsson P

4

1 reference

7 February 2018

publication date

1 January 1998

1 reference

7 February 2018

published in

Thrombosis Research

1 reference

7 February 2018

volume

89

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

41-50

1 reference

7 February 2018

A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Heparin free long-term extracorporeal circulation using bioactive surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Twenty-four-hour heparin-free veno-right ventricular ECMO: an experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

A New Model for Evaluation of Biocompatibility: Combined Determination of Neoepitopes in Blood and on Artificial Surfaces Demonstrates Reduced Complement Activation by Immobilization of Heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Immobilized heparin inhibits the increase in leukocyte surface expression of adhesion molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Effect of surface-immobilized heparin on the activation of adsorbed factor XII

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Purification and characterization of porcine C3. Studies of the biologically active protein and its split products

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Inhibition of the plasma contact activation system of immobilized heparin: relation to surface density of functional antithrombin binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Hageman factor fragment inhibitor in corn seeds: purification and characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

The corn inhibitor of blood coagulation factor XIIa. Crystallization and preliminary crystallographic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Role of surface in surface-dependent activation of Hageman factor (blood coagulation Factor XII)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Activation of blood coagulation at heparin-coated surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

Mechanisms of activation of the classical pathway of complement by Hageman factor fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2897%2900310-1

7 January 2021

10.1016/S0049-3848(97)00310-1

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018